{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:20:06Z","timestamp":1792592406038,"version":"4.5.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009331","name":"Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010270","name":"Capital Health Research and Development of Special Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Metabolic syndrome (MetS) and non-alcoholic fatty liver disease (NAFLD) are the leading chronic diseases worldwide. There are still many controversies about the association between serum bilirubin and MetS or NAFLD. This study aims to evaluate the association of serum total bilirubin (TBIL), direct bilirubin (DBIL), indirect bilirubin (IBIL) with MetS and NAFLD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Multiple databases were searched for relevant studies until November 2021. Randomized controlled trials, cross-sectional and cohort studies evaluating the association between serum bilirubin levels and MetS or NAFLD were included.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twenty-four cross-sectional and cohort studies with 101, 517 participants were finally analyzed. Fifteen studies and 6 studies evaluated the association between bilirubin and MetS or NAFLD in health screening population, respectively, while 3 studies evaluated the association between bilirubin and non-alcoholic steatohepatitis (NASH) in NAFLD patients. Random effect model analysis showed the inverse association between TBIL and MetS in male (95%CI=0.71-0.96) and gender-neutral (95%CI=0.61-0.91) group. However, no significant association was found in females. Notably, the inverse association between DBIL and MetS was noticed in male (95%CI=0.36-0.75), female (95%CI=0.16-0.58) and gender-neutral population (95%CI=0.67-0.92). IBIL level was inversely associated with MetS in females (95%CI=0.52-0.96), whereas no statistical correlation presented in males. TBIL was not statistically correlated with NAFLD in gender-neutral or male subgroup. Similarly, there were no association between DBIL or IBIL and NAFLD in gender-neutral subgroup. However, the negative correlation between DBIL and NAFLD existed in males (95%CI=0.76-0.96). In NAFLD patients, IBIL analysis showed an inverse association with NASH (95%CI=0.01-0.12).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Serum TBIL and DBIL levels, especially DBIL levels, assume an inverse correlation with MetS in healthy population. Serum IBIL is inversely associated with the onset and degree of NASH in NAFLD patients. Exogenous bilirubin supplement may be a potential strategy to assist in lowering the risk of developing MetS and NAFLD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic Review Registration<\/jats:title><jats:p><jats:uri>https:\/\/www.crd.york.ac.uk\/prospero\/<\/jats:uri>, identifier CRD42021293349<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.869579","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T08:53:06Z","timestamp":1658307186000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Association of Serum Bilirubin With Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Chen","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongping","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4501","article-title":"Trends in the Prevalence of Metabolic Syndrome in the United States, 2011-2016","volume":"323","author":"Hirode","year":"2020","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.4260","article-title":"Prevalence of the Metabolic Syndrome in the United States, 2003-2012","volume":"313","author":"Aguilar","year":"2015","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-00427-4","article-title":"Circadian Rhythms and the Gut Microbiota: From the Metabolic Syndrome to Cancer","volume":"16","author":"Bishehsari","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154770","article-title":"Non-Alcoholic Fatty Liver Disease, Insulin Resistance, Metabolic Syndrome and Their Association With Vascular Risk","volume":"6","author":"Emir","year":"2021","journal-title":"Metabolism: Clin Exp"},{"key":"B5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/2047487319886404","article-title":"The Metabolic Syndrome - What Is It and How Should It Be Managed","volume":"26","author":"Peter","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.freeradbiomed.2019.05.029","article-title":"Lipidomic Biomarkers and Mechanisms of Lipotoxicity in Non-Alcoholic Fatty Liver Disease","volume":"144","author":"Svegliati-Baroni","year":"2019","journal-title":"Free Radical Biol Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm10132812","article-title":"Association of Serum Bilirubin Level With Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study of 1672 Obese Children","volume":"10","author":"Bellarosa","year":"2021","journal-title":"J Clin Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15163","article-title":"Review Article: Shared Disease Mechanisms Between Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome - Translating Knowledge From Systems Biology to the Bedside","volume":"49","author":"Sookoian","year":"2019","journal-title":"Alimentary Pharmacol Ther"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/med.21660","article-title":"Bilirubin as a Signaling Molecule","volume":"40","author":"Vitek","year":"2020","journal-title":"Med Res Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29599","article-title":"Systemic Regulation of Bilirubin Homeostasis: Potential Benefits of Hyperbilirubinemia","volume":"67","author":"Fujiwara","year":"2018","journal-title":"Hepatology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2016.06.002","article-title":"Association of Circulating Total Bilirubin With the Metabolic Syndrome and Type 2 Diabetes: A Systematic Review and Meta-Analysis of Observational Evidence","volume":"42","author":"Nano","year":"2016","journal-title":"Diabetes Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2012.18.4.383","article-title":"Serum Bilirubin Levels Are Inversely Associated With Nonalcoholic Fatty Liver Disease","volume":"18","author":"Kwak","year":"2012","journal-title":"Clin Mol Hepatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/srep31006","article-title":"Zhang Y Et Al: Association Between Bilirubin and Risk of Non-Alcoholic Fatty Liver Disease Based on a Prospective Cohort Study","volume":"6","author":"Tian","year":"2016","journal-title":"Sci Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12155","article-title":"Unconjugated Bilirubin, a Potent Endogenous Antioxidant, Is Decreased in Patients With Non-Alcoholic Steatohepatitis and Advanced Fibrosis","volume":"28","author":"Salomone","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05114.x","article-title":"Unconjugated Hyperbilirubinemia Is Inversely Associated With Non-Alcoholic Steatohepatitis (NASH)","volume":"35","author":"Hjelkrem","year":"2012","journal-title":"Alimentary Pharmacol Ther"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2018.00662","article-title":"Genetically Regulated Bilirubin and Risk of Non-Alcoholic Fatty Liver Disease: A Mendelian Randomization Study","volume":"9","author":"Luo","year":"2018","journal-title":"Front Genet"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-019-00589-0","article-title":"Circulating Total Bilirubin and Risk of Non-Alcoholic Fatty Liver Disease in the PREVEND Study: Observational Findings and a Mendelian Randomization Study","volume":"35","author":"Kunutsor","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical Evaluation of the Newcastle-Ottawa Scale for the Assessment of the Quality of Nonrandomized Studies in Meta-Analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12902-020-00563-y","article-title":"Association of Total Bilirubin and Indirect Bilirubin Content With Metabolic Syndrome Among Kazakhs in Xinjiang","volume":"20","author":"Hao","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2019.02.009","article-title":"Total Bilirubin Independently Predicts Incident Metabolic Syndrome Among Community-Dwelling Women","volume":"13","author":"Kawamoto","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9621615","article-title":"Direct Bilirubin Levels and Risk of Metabolic Syndrome in Healthy Chinese Men","volume":"2017","author":"Li","year":"2017","journal-title":"BioMed Res Int"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431X20165252","article-title":"Serum Total Bilirubin Levels Are Negatively Correlated With Metabolic Syndrome in Aged Chinese Women: A Community-Based Study","volume":"50","author":"Zhong","year":"2017","journal-title":"Braz J Med Biol Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168253","article-title":"Change in Serum Bilirubin Level as a Predictor of Incident Metabolic Syndrome","volume":"11","author":"Lee","year":"2016","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0254-6450.2016.04.009","article-title":"[Association Between Serum Direct Bilirubin With Metabolic Syndrome and Its Components Based on a Longitudinal Health Check-Up Study]","volume":"37","author":"Chen","year":"2016","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2015.04.019","article-title":"Serum Bilirubin Levels Predict Future Development of Metabolic Syndrome in Healthy Middle-Aged Nonsmoking Men","volume":"128","author":"Huang","year":"2015","journal-title":"Am J Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2014.04.006","article-title":"Serum Bilirubin as a Predictor of Incident Metabolic Syndrome: A 4-Year Retrospective Longitudinal Study of 6205 Initially Healthy Korean Men","volume":"40","author":"Lee","year":"2014","journal-title":"Diabetes Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2011.03.001","article-title":"Relationships Between Serum Total Bilirubin Levels and Metabolic Syndrome in Korean Adults","volume":"23","author":"Choi","year":"2013","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-012-0447-5","article-title":"Total Bilirubin Is Inversely Associated With Metabolic Syndrome but Not a Risk Factor for Metabolic Syndrome in Japanese Men and Women","volume":"50","author":"Oda","year":"2013","journal-title":"Acta Diabetol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-0407.2011.00138.x","article-title":"Low Serum Total Bilirubin Concentrations Are Associated With Increased Prevalence of Metabolic Syndrome in Chinese","volume":"3","author":"Wu","year":"2011","journal-title":"J Diabetes"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2010.2453","article-title":"Inverse Association Between Total Bilirubin and Metabolic Syndrome in Rural Korean Women","volume":"20","author":"Kwon","year":"2011","journal-title":"J Womens Health (Larchmt)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2010.06.003","article-title":"Inverse Relationship Between Fasting Direct Bilirubin and Metabolic Syndrome in Korean Adults","volume":"411","author":"Hwang","year":"2010","journal-title":"Clin Chim Acta"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-010-9417-2","article-title":"Total, Direct, and Indirect Serum Bilirubin Concentrations and Metabolic Syndrome Among the Korean Population","volume":"39","author":"Jo","year":"2010","journal-title":"Endocrine"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2008.07.021","article-title":"Serum Bilirubin Is Inversely Associated With Insulin Resistance and Metabolic Syndrome Among Children and Adolescents","volume":"203","author":"Lin","year":"2009","journal-title":"Atherosclerosis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e318291fefe","article-title":"Serum Bilirubin Level Is Inversely Associated With Nonalcoholic Steatohepatitis in Children","volume":"57","author":"Puri","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037241","article-title":"A Cohort Study of Serum Bilirubin Levels and Incident Non-Alcoholic Fatty Liver Disease in Middle Aged Korean Workers","volume":"7","author":"Chang","year":"2012","journal-title":"PLoS One"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2011.11.017","article-title":"Unconjugated Hyperbilirubinemia in Patients With Non-Alcoholic Fatty Liver Disease: A Favorable Endogenous Tesponse","volume":"45","author":"Kumar","year":"2012","journal-title":"Clin Biochem"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-0315-7","article-title":"NAFLD - Sounding the Alarm on a Silent Epidemic","volume":"17","author":"Lazarus","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/srep09886","article-title":"Bilirubin Increases Insulin Sensitivity by Regulating Cholesterol Metabolism, Adipokines and PPARgamma Levels","volume":"5","author":"Liu","year":"2015","journal-title":"Sci Rep"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/srep30051","article-title":"Features of an Altered AMPK Metabolic Pathway in Gilbert\u2019s Syndrome, and Its Role in Metabolic Health","volume":"6","author":"Molzer","year":"2016","journal-title":"Sci Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/srep29240","article-title":"Bilirubin Is an Endogenous Antioxidant in Human Vascular Endothelial Cells","volume":"6","author":"Ziberna","year":"2016","journal-title":"Sci Rep"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2019.108072","article-title":"CRISPR Cas9-Mediated Deletion of Biliverdin Reductase a (BVRA) in Mouse Liver Cells Induces Oxidative Stress and Lipid Accumulation","volume":"672","author":"Gordon","year":"2019","journal-title":"Arch Biochem Biophys"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-021-00569-6","article-title":"PPAR Control of Metabolism and Cardiovascular Functions","volume":"18","author":"Montaigne","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/0304-4165(93)90013-x","article-title":"Taroh Kinoshita B, Seiji Morisawa: A Beneficial Role of Bile Pigments as an Endogenous Tissue Protector: Anticomplement Effects of Biliverdin and Conjugated Bilirubin","volume":"1158","author":"Tatsuyoshi Nakagami","year":"1993","journal-title":"Biochim Biophys Acta"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(85)80779-0","article-title":"Sex Differences of Nicotinate-Induced Hyperbilirubinemia in Gilbert\u2019s Syndrome. Implication of Bilitranslocase Function","volume":"1","author":"Gentile","year":"1985","journal-title":"J Hepatol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12876-019-0931-2","article-title":"The Frequency, Clinical Course, and Health Related Quality of Life in Adults With Gilbert\u2019s Syndrome: A Longitudinal Study","volume":"19","author":"Kamal","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21249493","article-title":"Natural Product Heme Oxygenase Inducers as Treatment for Nonalcoholic Fatty Liver Disease","volume":"21","author":"Stec","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.138.12.1375","article-title":"Chaudry IH: Sex Differences in Hepatic Heme Oxygenase Expression and Activity Following Trauma and Hemorrhagic Shock","volume":"138","author":"Toth","year":"2003","journal-title":"Arch Surg"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(81)92463-6","article-title":"Iron and the Sex Difference in Heart Disease Risk","volume":"1","author":"Sullivan","year":"1981","journal-title":"Lancet"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00396.2016","article-title":"Mice With Hyperbilirubinemia Due to Gilbert\u2019s Syndrome Polymorphism Are Resistant to Hepatic Steatosis by Decreased Serine 73 Phosphorylation of PPARalpha","volume":"312","author":"Hinds","year":"2017","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B51","doi-asserted-by":"publisher","first-page":"8689","DOI":"10.1038\/s41598-020-65481-4","article-title":"A Gilbert Syndrome-Associated Haplotype Protects Against Fatty Liver Disease in Humanized Transgenic Mice","volume":"10","author":"Landerer","year":"2020","journal-title":"Sci Rep"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29367","article-title":"The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance From the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic Fatty Liver Disease: A Systematic Review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-017-0556-1","article-title":"NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk","volume":"34","author":"Stefano","year":"2017","journal-title":"Adv Ther"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-Alcoholic Fatty Liver Disease as a Cause and a Consequence of Metabolic Syndrome","volume":"2","author":"Yki-Jarvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-013-2829-9","article-title":"Adipose Tissue Is Inflamed in NAFLD Due to Obesity but Not in NAFLD Due to Genetic Variation in PNPLA3","volume":"56","author":"Lallukka","year":"2013","journal-title":"Diabetologia"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102152","article-title":"Bilirubin Deficiency Renders Mice Susceptible to Hepatic Steatosis in the Absence of Insulin Resistance","volume":"47","author":"Chen","year":"2021","journal-title":"Redox Biol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1341","article-title":"Induction of Mild Hyperbilirubinemia: Hype or Real Therapeutic Opportunity","volume":"106","author":"Vitek","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.594574","article-title":"Bilirubin Nanoparticles Reduce Diet-Induced Hepatic Steatosis, Improve Fat Utilization, and Increase Plasma Beta-Hydroxybutyrate","volume":"11","author":"Hinds","year":"2020","journal-title":"Front Pharmacol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2006.12.069","article-title":"\u2018\u2018iatrogenic Gilbert Syndrome\u2019\u2019\u2013a Strategy for Reducing Vascular and Cancer Risk by Increasing Plasma Unconjugated Bilirubin","volume":"69","author":"McCarty","year":"2007","journal-title":"Med Hypotheses"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.869579\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T08:53:11Z","timestamp":1658307191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.869579\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,20]]},"references-count":60,"alternative-id":["10.3389\/fendo.2022.869579"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.869579","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,20]]},"article-number":"869579"}}